Skip to main content
. 2022 Jul 15;29(7):4970–4980. doi: 10.3390/curroncol29070395

Figure 4.

Figure 4

Participant preferences: (a) In an allogeneic transplant candidate patient, what do you think is the optimal period of JAK inhibitor therapy prior to transplantation? (b) In a transplant candidate patient, what is the timing of withdrawal of the JAK inhibitor adopted by your center?